-
ARK Disrupt Issue 143: SpaceX, Autonomous, ITS World Congress, Cancer Detection, Meituan, Bitmain, & Paige.AI
Please enjoy ARK Disrupt Issue 143. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
Cancer Detection Could be Faster and Cheaper with Cepheid’s New Test
Today, the detection of cancer is time consuming and expensive. Tissue samples from molecular diagnostic tests must be mailed to a lab and sequenced or otherwise analyzed. In the United States, the process can take between seven and fourteen days, and costs $4,000 to $8,000. Test results from Foundation Medicine , Myriad Genetics , and […]
Immunosignatures Detect Cancer at Very Early Stages
A new blood test, called immunosignaturing 1, has the potential to change the cancer-care landscape dramatically. Now in research labs, it promises to detect breast cancer as early as a year before traditional diagnosis, with 90% certainty. Early diagnosis is an important factor in predicting cancer survival rates. Patients diagnosed with Stage I breast cancer […]
